BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 7168176)

  • 1. [Priming of the cervix with prostaglandins in the first and second trimester].
    Brabec W
    Wien Klin Wochenschr; 1982 Oct; 94(20):554-8. PubMed ID: 7168176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical experience with sulprostone (author's transl)].
    Brabec W; Dapunt O; Bichler A
    Wien Klin Wochenschr; 1981 Mar; 93(6):193-7. PubMed ID: 7281695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Termination of normal and pathological pregnancy with Sulprostone.
    Fischer Z; Chwalisz K; Michałkiewicz W
    Acta Chir Hung; 1986; 27(3):151-6. PubMed ID: 3825407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Induction of abortion during the second and third trimester of pregnancy with sulprostone (author's transl)].
    Heinzl S; Winkler C
    Geburtshilfe Frauenheilkd; 1981 Mar; 41(3):231-6. PubMed ID: 7215768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new therapeutic approach for terminating intact and disturbed pregnancies: three years of experience with the prostaglandin E2-derivative sulprostone (SHB 286) (author's transl)].
    Schmidt-Gollwitzer K; Schüssler B; Elger W; Schmidt-Gollwitzer M
    Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):667-75. PubMed ID: 478268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined pericervical and intramuscular administration of prostaglandin for the termination of pregnancy in the 2d and 3d trimester].
    Grünberger W; Husslein P
    Geburtshilfe Frauenheilkd; 1983 Apr; 43(4):240-4. PubMed ID: 6553545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preoperative cervical dilatation in abortion during the 1st trimester with sulprostone].
    Schulz BO; Gethmann U; Lehmann F
    Geburtshilfe Frauenheilkd; 1984 Mar; 44(3):185-7. PubMed ID: 6562984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of a new synthetic prostaglandin (sulprostone) in various obstetrical conditions].
    Melis GB; Fruzzetti F; Paoletti AM; Strigini F; Baisi F; Gargiulo T; Pallotti A; Solla E; Sesselego G; Fioretti P
    Minerva Ginecol; 1982 Mar; 34(3):183-90. PubMed ID: 7045735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cervix priming in induced abortion in the 1st trimester using intracervical administration of sulprostone gel].
    Rath W; Meyer D; Harder D; Hilgers R; Kuhn W
    Geburtshilfe Frauenheilkd; 1985 Jan; 45(1):51-6. PubMed ID: 3845028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of abortion with sulprostone, a uteroselective prostaglandin E2 derivative: intramuscular route of application.
    Schmidt-Gollwitzer K; Hoebich D; Hardt W; Schuessler B; Schmidt-Gollwitzer M
    Int J Fertil; 1981; 26(2):86-93. PubMed ID: 6114070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of sulprostone for induction of preoperative cervical dilation or uterine evacuation: a comparison among the effects of different treatment schedules.
    Fruzzetti F; Melis GB; Strigini F; Vettori C; Ricci C; Fioretti P
    Obstet Gynecol; 1988 Nov; 72(5):704-8. PubMed ID: 3173921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preoperative cervix priming in the 1st trimester: initial clinical experiences with a combination of Pluronic F 127 and sulprostone].
    Heine O
    Geburtshilfe Frauenheilkd; 1988 Feb; 48(2):102-5. PubMed ID: 3366345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulprostone for preoperative cervical dilatation in primigravidae scheduled for late first trimester termination of pregnancy.
    Jerve F; Fylling P
    Arch Gynecol; 1983; 233(3):199-203. PubMed ID: 6625666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of prostaglandins in pregnancy termination in the 1st and 2d trimester].
    Rath W
    Wien Klin Wochenschr; 1987 Nov; 99(21):741-51. PubMed ID: 3321720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulprostone (Nalador) versus gemeprost (Cervagem) for cervical priming in the termination of pregnancy during the first trimester.
    Heinzl S; Hendry M
    Contraception; 1987 Mar; 35(3):271-82. PubMed ID: 3608482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experiences with sulproston for cervical priming in pregnancy termination in the 1st trimester].
    Heinzl S; Winkler C; Allemann F
    Gynakol Rundsch; 1982; 22(4):233-40. PubMed ID: 7160659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dose-dependent effect of locally administered sulprostone gel on serum luteal and placental hormones in cervix priming in the 1st trimester].
    Rath W; Pitzel L; Hilgers R; Kuhn W
    Zentralbl Gynakol; 1989; 111(10):634-44. PubMed ID: 2750356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of various intracervically administered PG gel preparations for termination of first trimester pregnancies.
    Rath W; Meyer D; Hildebrandt J; Hilgers R; Kuhn W
    Contraception; 1983 Sep; 28(3):209-22. PubMed ID: 6357631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostaglandins for the termination of pathological pregnancies in the 2d trimester].
    Gruber W
    Wien Klin Wochenschr; 1982 Oct; 94(20):558-60. PubMed ID: 6963074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The induction of abortion and the priming of the cervix with prostaglandin F2 alpha and prostaglandin E2 by intra-amniotic, extra-amniotic and intra-cervical application (author's transl)].
    Schmidt W; Widmaier G; Ditz S; Kubli F
    Geburtshilfe Frauenheilkd; 1982 Feb; 42(2):118-22. PubMed ID: 6917804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.